The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis

被引:39
作者
Shen, Xin [1 ]
Peng, Yu [2 ]
Li, Hanmin [3 ]
机构
[1] Hubei Univ Chinese Med, Dept Lab Med, Wuhan, Hubei, Peoples R China
[2] Hubei Univ Chinese Med, Dept Informat Engn, Wuhan, Hubei, Peoples R China
[3] Hubei Univ Chinese Med, Hubei Prov Acad Tradit Chinese Med, Hubei Prov Hosp Tradit Chinese Med, Hepat Dis Inst,Affiliated Hosp, Wuhan, Hubei, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
基金
美国国家科学基金会;
关键词
hedgehog signaling pathway; repair-associated inflammation; immune-modulatory action; hedgehog pathway inhibitor; liver fibrosis; HEPATIC STELLATE CELLS; KILLER T-CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; SONIC-HEDGEHOG; NATURAL-KILLER; MESENCHYMAL TRANSITION; CARBON-TETRACHLORIDE; CYCLE PROGRESSION; SUPPRESSOR-CELLS; APOPTOTIC BODIES;
D O I
10.3389/fimmu.2017.01450
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver fibrosis is a wound healing response initiated by inflammation responding for different iterative parenchymal damages caused by diverse etiologies. Immune cells, which exert their ability of either inducing injury or promoting repair, have been regarded as crucial participants in the fibrogenic response. A characteristic feature of the fibrotic microenvironment associated with chronic liver injury is aberrant activation of hedgehog (Hh) signaling pathway. Growing evidence from a number of different studies in vivo and in vitro has indicated that immune-mediated events involved in liver fibrogenesis are regulated by Hh signaling pathway. In this review, we emphasize the impacts of injury-activated Hh signaling on liver fibrogenesis through modulating repair-related inflammation and focus on the regulatory action of aberrant Hh signaling on repair-related inflammatory responses mediated by hepatic classical and non-classical immune cell populations in the progression of liver fibrosis. Moreover, we also assess the potentiality of Hh pathway inhibitors as good candidates for anti-fibrotic therapeutic agents because of their immune regulation actions for fibrogenic liver repair. The identification of immune-modulatory mechanisms of Hh signaling pathway underlying the fibrotic process of chronic liver diseases might provide a basis for Hh-centered therapeutic strategies for liver fibrosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
    Gao-Liang Zou
    Shi Zuo
    Shuang Lu
    Rui-Han Hu
    Yin-Ying Lu
    Jing Yang
    Kai-Sheng Deng
    Ye-Ting Wu
    Mao Mu
    Juan-Juan Zhu
    Jing-Zhang Zeng
    Bao-Fang Zhang
    Xian Wu
    Xue-Ke Zhao
    Hai-Yang Li
    World Journal of Gastroenterology, 2019, 25 (30) : 4222 - 4234
  • [42] Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
    Zou, Gao-Liang
    Zuo, Shi
    Lu, Shuang
    Hu, Rui-Han
    Lu, Yin-Ying
    Yang, Jing
    Deng, Kai-Sheng
    Wu, Ye-Ting
    Mu, Mao
    Zhu, Juan-Juan
    Zeng, Jing-Zhang
    Zhang, Bao-Fang
    Wu, Xian
    Zhao, Xue-Ke
    Li, Hai-Yang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (30) : 4222 - 4234
  • [43] Theacrine ameliorates experimental liver fibrosis in rats by lowering cholesterol storage via activation of the Sirtuin 3-farnesoid X receptor signaling pathway
    Lv, Xi-Ting
    Wang, Ruo-Hong
    Liu, Xiao-Ting
    Ye, Yu-Jing
    Liu, Xin-Yu
    Qiao, Jing-Da
    Wang, Guo-En
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 364
  • [44] miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis
    Niu, Xuemin
    Fu, Na
    Du, Jinghua
    Wang, Rongqi
    Wang, Yang
    Zhao, Suxian
    Du, Huijuan
    Wang, Baoyu
    Zhang, Yuguo
    Sun, Dianxing
    Nan, Yuemin
    FEBS LETTERS, 2016, 590 (16) : 2709 - 2724
  • [45] Th2-Associated Alternative Kupffer Cell Activation Promotes Liver Fibrosis without Inducing Local Inflammation
    Lopez-Navarrete, Giuliana
    Ramos-Martinez, Espiridion
    Suarez-Alvarez, Karina
    Aguirre-Garcia, Jesus
    Ledezma-Soto, Yadira
    Leon-Cabrera, Sonia
    Gudino-Zayas, Marco
    Guzman, Carolina
    Gutierrez-Reyes, Gabriela
    Hernandez-Ruiz, Joselin
    Camacho-Arroyo, Ignacio
    Robles-Diaz, Guillermo
    Kershenobich, David
    Terrazas, Luis I.
    Escobedo, Galileo
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2011, 7 (09): : 1273 - 1286
  • [46] Roxarsone inhibits hepatic stellate cell activation and ameliorates liver fibrosis by blocking TGF-β1/Smad signaling pathway
    Li, Ting-Ting
    Su, Xiao-Wei
    Chen, Lin-Lin
    Zhang, Wan-Nian
    Zhang, Jun-Ping
    Wang, Yan
    Xu, Wei-Heng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [47] Ursodesoxycholic acid alleviates liver fibrosis via proregeneration by activation of the ID1-WNT2/HGF signaling pathway
    Dong, Xi
    Luo, Yun
    Lu, Shan
    Ma, Han
    Zhang, Wenchao
    Zhu, Yue
    Sun, Guibo
    Sun, Xiaobo
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (02):
  • [48] Alpha-pinene ameliorates liver fibrosis by suppressing oxidative stress, inflammation, and the TGF-β/Smad3 signaling pathway
    Noroozi, Fatemeh
    Asle-Rousta, Masoumeh
    Amini, Rahim
    Sahraeian, Zeinab
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2025, 28 (04) : 451 - 460
  • [49] Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis
    Xu, Ming-Yi
    Hu, Jun-Jie
    Shen, Jie
    Wang, Mei-Ling
    Zhang, Qing-Qing
    Qu, Ying
    Lu, Lun-Gen
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (11): : 2237 - 2245
  • [50] P-EKKE Alleviates Myocardial Infarction (MI) in MI Rats by Inhibiting Hedgehog Signaling Pathway-mediated Inflammation and Inhibiting α-actin Mediated Myocardial Fibrosis
    Song, Guixian
    Ruan, Zhongbao
    Wang, Ruzhu
    Ren, Yin
    Zhu, Li
    Shen, Yahui
    Wang, Bin
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (07) : 1164 - 1171